Jun 16, 2015, 08:45 ET
COLUMBIA, S.C., June 16, 2015 /PRNewswire/ -- BDI Pharma, Inc., the nation's fastest growing, independently owned specialty pharmaceutical distributor, today announced a 37 percent increase in first quarter sales revenue over the same time period in 2014. BDI Pharma is currently in their 20th year serving the specialty pharmaceutical marketplace.
Logo - http://photos.prnewswire.com/prnh/20150615/223157LOGO
One driver for the company's success is the increased emphasis on strategic partnerships with manufacturers. The company has historically focused on providing innovative customer facing programs centered on high quality distribution services. More recently, BDI Pharma has made a concerted effort to invest in and further develop a portfolio of support services and solutions to address the many challenges faced by manufacturers from product launch to commercialization, thus better serving customers as well as providing needed services to the manufacturers.
To contact a manufacturer relations specialist in regards to solutions available, contact BDI Pharma at 1-800-948-9834.
About BDI Pharma, Inc.
BDI Pharma creates customized solutions to meet the distribution and support needs of manufacturers, healthcare providers and patients throughout the life of each product within the specialty, niche pharmaceutical market. We aspire towards financial viability for all parties involved, employ a partnership oriented approach and drive value for our customers. We are continuously refining the concept of niche distribution to provide solutions beyond the traditional wholesaler model and operate as an extension of our partners' sales force, create demand and move market share with each transaction. Our approach of serving the manufactures as well as healthcare providers and patients over the last two decades has proven successful regardless of varying market conditions. This is further supplemented through innovative supply solutions, extensive product knowledge, 24/7 emergency availability and urgent need delivery. The company's website www.bdipharma.com serves as an invaluable resource for reference material, educational literature and online ordering. Proprietary programs offering comprehensive reimbursement services - www.bdiaccess.com and 855-BDI-CARE - and product consignment - www.bdivantageplus.com - are just a few of the solutions tailored to the needs of the entire healthcare community. BDI Pharma's product portfolio includes IVIG, branded and generic specialty pharmaceuticals, chemotherapy, vaccines, albumin, coagulation factors, high-titer or "hyper" immune globulins, and other niche, specialty products. BDI Pharma is recognized as an "ADR," or Authorized Distributor of Record, for all of the manufacturers it represents.
SOURCE BDI Pharma, Inc.
Share this article